Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic
Brain metastases are the most frequent cancer-related neurological complication and are associated with a negative impact in neurocognitive function, quality of life deterioration, and poor prognosis [1].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: N. Vilari ño, J. Bruna, J. Bosch-Barrera, M. Valiente, E. Nadal Tags: Hot Topic Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Immunotherapy | Neurology | Non-Small Cell Lung Cancer